This document is an agent authorization letter from Screeneo Innovation SA to Shenzhen Anbotek Compliance Laboratory Limited. It grants them the authority to act on Screeneo's behalf in all matters relating to the application for equipment certification with the Federal Communications Commission (FCC).
The letter confirms that any actions taken by Shenzhen Anbotek Compliance Laboratory Limited will have the same effect as if carried out by Screeneo Innovation SA directly. Screeneo acknowledges full responsibility for complying with the terms and conditions of certification as specified by DERYCOM CERTIFICATION SERVICES, INC., even while utilizing the services of the authorized agent.
Furthermore, Screeneo Innovation SA certifies that they are not subject to any denial of federal benefits, including FCC benefits, as outlined in Section 5301 of the Anti-Drug Abuse Act of 1988. They also confirm that no party involved in the application is subject to a denial of federal benefits that includes FCC benefits, as defined in 47 CFR §1.2002(b).
The letter is signed by Dan Mamane, CEO & President of Screeneo Innovation SA.